Showing results (371-380 of 673) with videos related to

Sort By:
Pageof 68
Intestinal Research|February 28, 2017
Analysis of the clinical indications for opiate use in inflammatory bowel diseaseYouran Gao, Sundas Khan, Meredith Akerman, et al.
Intestinal Research|February 28, 2017
Determining the optimal surveillance interval after a colonoscopic polypectomy for the Korean population?Jung Lok Lee, Jae Myung Cha, Hye Min Lee, et al.
Intestinal Research|February 28, 2017
Metronidazole-induced encephalopathy in a patient with Crohn's diseaseJihye Kim, Jaeyoung Chun, Jae Yong Park, et al.
Intestinal Research|February 28, 2017
Capsule retention caused by duodenal metastases from primary appendiceal adenocarcinomaJen-Wei Chou, Ken-Sheng Cheng
Intestinal Research|August 3, 2019
Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behaviorRupa Banerjee, Partha Pal, Susan Hutfless, et al.
Intestinal Research|September 3, 2019
Importance of nutritional therapy in the management of intestinal diseases: beyond energy and nutrient supplySeong-Eun Kim
Intestinal Research|October 30, 2018
Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel diseaseDeborah Chew, Wong Zhiqin, Norhayati Ibrahim, et al.
Intestinal Research|February 21, 2019
Risk of surgery in patients with stricturing type of Crohn's disease at the initial diagnosis: a single center experienceYuji Maehata, Yutaka Nagata, Tomohiko Moriyama, et al.
Intestinal Research|January 6, 2025
Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician surveyJulajak Limsrivilai, Allen Yu-Hung Lai, Silvia T H Li, et al.
Intestinal Research|December 22, 2024
Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort studyRobert Gilmore, Richard Fernandes, Imogen Hartley, et al.
Pageof 68